Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial

被引：6
|
作者：
Vart, Priya [1 ]
Jongs, Niels [1 ]
Wheeler, David C. [2 ]
Heerspink, Hiddo J. L. [1 ,3 ]
Langkilde, Anna Maria [4 ]
Chertow, Glenn M. [5 ,6 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] UCL, Dept Renal Med, London, England
[3] George Inst Global Hlth, Sydney, NSW, Australia
[4] AstraZeneca, BioPharmaceut R&D, Gotherburg, Sweden
[5] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2023年 / 6卷 / 04期
关键词：
RACIAL-DIFFERENCES; RISK;
D O I：
10.1001/jamanetworkopen.2023.10877
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial (vol 6, e2310877, 2023)
    Vart, P.
    Jongs, N.
    Wheeler, D. C.
    Heerspink, H. J. L.
    Langkilde, A. M.
    Chertow, G. M.
    JAMA NETWORK OPEN, 2023, 6 (05)
  • [2] Safety Profile and Effectiveness of Dapagliflozin in Pediatric Patients with Chronic Kidney Disease
    Van Reeth, Olil
    Caliment, Ancuta
    Garcia, Isabel de la Fuente
    Niel, Olivier
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 463 - 467
  • [3] Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
    Sleem, Amber
    Effron, Mark B.
    Stebbins, Amanda
    Wruck, Lisa M.
    Marquis-Gravel, Guillaume
    Munoz, Daniel
    Re, Richard N.
    Gupta, Kamal
    Pepine, Carl J.
    Jain, Sandeep K.
    Girotra, Saket
    Whittle, Jeffrey
    Benziger, Catherine P.
    Farrehi, Peter M.
    Knowlton, Kirk U.
    Polonsky, Tamar S.
    Roe, Matthew T.
    Rothman, Russell L.
    Harrington, Robert A.
    Jones, W. Schuyler
    Hernandez, Adrian F.
    JAMA CARDIOLOGY, 2023, 8 (11) : 1061 - 1069
  • [4] Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
    Provenzano, Michele
    Puchades, Maria Jesus
    Garofalo, Carlo
    Jongs, Niels
    D'Marco, Luis
    Andreucci, Michele
    De Nicola, Luca
    Gorriz, Jose Luis
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (08): : 1569 - 1580
  • [5] Effectiveness and Safety of Multicomponent Physical Training in Patients With Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Clinical Trial
    Mazzarin, Camila Monteiro
    Silveira, Bruna Roberta
    Lamezon, Ana Cristina
    Luna, Bruna Cavon
    Valderramas, Silvia
    HEALTH SERVICES INSIGHTS, 2023, 16
  • [6] Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial
    Wheeler, David C.
    Jongs, Niels
    Stefansson, Bergur, V
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan Fan
    Langkilde, Anna Maria
    McMurray, John J., V
    Rossing, Peter
    Nowicki, Michal
    Wittmann, Istvan
    Correa-Rotter, Ricardo
    Sjostrom, C. David
    Toto, Robert D.
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (09) : 1647 - 1656
  • [7] Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients A Randomized Clinical Trial
    Singh, Ajay K.
    Cizman, Borut
    Carroll, Kevin
    McMurray, John J., V
    Perkovic, Vlado
    Jha, Vivekanand
    Johansen, Kirsten L.
    Lopes, Renato D.
    Macdougall, Iain C.
    Obrador, Gregorio T.
    Waikar, Sushrut S.
    Wanner, Christoph
    Wheeler, David C.
    Wiecek, Andrzej
    Stankus, Nicole
    Strutz, Frank
    Blackorby, Allison
    Cobitz, Alexander R.
    Meadowcroft, Amy M.
    Paul, Gitanjali
    Ranganathan, Prerna
    Sedani, Sangeeta
    Solomon, Scott
    JAMA INTERNAL MEDICINE, 2022, 182 (06) : 592 - 602
  • [8] EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SUBGROUP ANALYSIS OF ADAPTABLE
    Mehta, Harsh
    Gupta, Kamal
    Kim, Hwasoon
    Wruck, Lisa
    Ahmad, Faraz S.
    Benziger, Catherine P.
    Farrehi, Peter M.
    Girotra, Saket
    Kripalani, Sunil
    Munoz, Daniel
    Polonsky, Tamar
    Sharlow, Amber
    Whittle, Jeffrey
    Hernandez, Adrian F.
    Jones, W. Schuyler
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 960 - 960
  • [9] Use of probiotics in patients with chronic kidney disease on hemodialysis: a randomized clinical trial
    de Araujo, Erica Maria Rodrigues
    Meneses, Gdayllon Cavalcante
    Carioca, Antonio Augusto Ferreira
    Martins, Alice Maria Costa
    Daher, Elizabeth De Francesco
    Junior, Geraldo Bezerra da Silva
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (02): : 152 - 161
  • [10] Original Investigation | Nephrology Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension A Secondary Analysis of a Randomized Clinical Trial
    Ishani, Areef
    Hau, Cynthia
    Raju, Srihari
    Wise, Jessica K.
    Glassman, Peter A.
    Taylor, Addison A.
    Ferguson, Ryan E.
    Cushman, William C.
    Leatherman, Sarah M.
    JAMA NETWORK OPEN, 2024, 7 (12)
12345